Literature DB >> 30157725

Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.

Thomas J Nicholson1,2, Simon A Jackson2,3, Bradley I Croft1, Raymond H J Staals3,4, Peter C Fineran2,3, Chris M Brown1,2.   

Abstract

CRISPR-Cas systems provide bacteria and archaea with adaptive immunity against invading genetic elements, such as plasmids, bacteriophages and archaeal viruses. They consist of cas genes and CRISPR loci, which store genetic memories of previously encountered invaders as short sequences termed spacers. Spacers determine the specificity of CRISPR-Cas defence and immunity can be gained or updated by the addition of new spacers into CRISPR loci. There are two main routes to spacer acquisition, which are known as naïve and primed CRISPR adaptation. Naïve CRISPR adaptation involves the de novo formation of immunity, independent of pre-existing spacers. In contrast, primed CRISPR adaptation (priming) uses existing spacers to enhance the acquisition of new spacers. Priming typically results in spacer acquisition from locations near the site of target recognition by the existing (priming) spacer. Primed CRISPR adaptation has been observed in several type I CRISPR-Cas systems and it is potentially widespread. However, experimental evidence is unavailable for some subtypes, and for most systems, priming has only been shown in a small number of hosts. There is also no current evidence of priming by other CRISPR-Cas types. Here, we used a bioinformatic approach to search for evidence of priming in diverse CRISPR-Cas systems. By analysing the clustering of spacers acquired from phages, prophages and archaeal viruses, including strand and directional biases between subsequently acquired spacers, we demonstrate that two patterns of primed CRISPR adaptation dominate in type I systems. In addition, we find evidence of a priming-like pathway in type II CRISPR-Cas systems.

Entities:  

Keywords:  CRISPR-Cas; adaptation; adaptive immunity; primed; priming; spacer acquisition

Mesh:

Year:  2018        PMID: 30157725      PMCID: PMC6546363          DOI: 10.1080/15476286.2018.1509662

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  15 in total

1.  CRISPR-Cas: more than ten years and still full of mysteries.

Authors:  Emmanuelle Charpentier; Alexander Elsholz; Anita Marchfelder
Journal:  RNA Biol       Date:  2019-04       Impact factor: 4.652

2.  Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.

Authors:  B N J Watson; R A Easingwood; B Tong; M Wolf; G P C Salmond; R H J Staals; M Bostina; P C Fineran
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

3.  The Rcs stress response inversely controls surface and CRISPR-Cas adaptive immunity to discriminate plasmids and phages.

Authors:  Leah M Smith; Simon A Jackson; Lucia M Malone; James E Ussher; Paul P Gardner; Peter C Fineran
Journal:  Nat Microbiol       Date:  2021-01-04       Impact factor: 17.745

4.  A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.

Authors:  Lucia M Malone; Suzanne L Warring; Simon A Jackson; Carolin Warnecke; Paul P Gardner; Laura F Gumy; Peter C Fineran
Journal:  Nat Microbiol       Date:  2019-12-09       Impact factor: 17.745

Review 5.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 6.  The arms race between bacteria and their phage foes.

Authors:  Hannah G Hampton; Bridget N J Watson; Peter C Fineran
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

7.  CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids.

Authors:  Rafael Pinilla-Redondo; Jakob Russel; David Mayo-Muñoz; Shiraz A Shah; Roger A Garrett; Joseph Nesme; Jonas S Madsen; Peter C Fineran; Søren J Sørensen
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

8.  Cas4-Cas1 fusions drive efficient PAM selection and control CRISPR adaptation.

Authors:  Cristóbal Almendros; Franklin L Nobrega; Rebecca E McKenzie; Stan J J Brouns
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

Review 9.  CRISPR-Cas Systems and the Paradox of Self-Targeting Spacers.

Authors:  Franziska Wimmer; Chase L Beisel
Journal:  Front Microbiol       Date:  2020-01-22       Impact factor: 5.640

10.  Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.

Authors:  Cas Mosterd; Sylvain Moineau
Journal:  mSphere       Date:  2021-05-19       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.